Management of CVD Risk in the Perimenopausal Woman 2006

This Educational Course, held on May 12 & 13, 2006 at the European Heart House was conducted under the auspices of the Women at Heart Initiative

Course Objective:

Build an expert position on the interdisciplinary treatment algorithm for menopausal women with climacteric symptoms under consideration of cardiovascular risk factors, with particular interest on blood pressure.
Access the Programme

Presentation Title	Authors	Session	Date
Cardiovascular effect of HRT	Stevenson J.	Management of perimenopausal women: the gynaecologist's perspective	12 May 2006
Cardiovascular risk prediction in stable angina	Daly C.	Management of perimenopausal women: the cardiologist's perspective	12 May 2006
Diabetes in Women	Kaaja R.	Management of perimenopausal women: the cardiologist's perspective	12 May 2006
Drospirenone, a new progestin with Aldosterone receptor antagonist activity	Collins P.	Management of Cardiovascular Risk in the Perimenopausal Woman	12 May 2006
HRT - what is it?	Gambacciani M.	Management of perimenopausal women: the gynaecologist's perspective	12 May 2006
Impact of cardiovascular risk factors : difference between men and women	Stramba-Badiale M.	Introduction: Epidemiology of CVD in women. The European view	12 May 2006
Importance of hypertension in the perimenopausal woman	Preston R.	Introduction: Epidemiology of CVD in women. The European view	12 May 2006
Is there a window of opportunity?	Mikkola T.	Management of perimenopausal women: the gynaecologist's perspective	12 May 2006
Menopause and resulting medical needs	Hadji P.	Introduction: Epidemiology of CVD in women. The European view	12 May 2006
Menopause as a cardiovascular risk factor	Rosano G.	Introduction: Epidemiology of CVD in women. The European view	12 May 2006
Metabolic syndrome in women	Kaaja R.	Management of perimenopausal women: the cardiologist's perspective	12 May 2006
Where do we stand adter the latest WHI data?	Palacios S.	Management of perimenopausal women: the gynaecologist's perspective	12 May 2006

Is your ER department equipped and aware of the ESC guidelines supporting early use of dual antiplatelet therapy in ACS patients?

Absolutely
Yes, in most cases
Not sure

Site Map | Contact Us | Terms & Conditions | Privacy